Metoclopramide Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Metoclopramide Hydrochloride
US Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Metoclopramide Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 9 NDC API, 14 Listed Suppliers, $ API Reference Price

26 API Suppliers
10 USDMF
4 CEP/COS
1 JDMF
3 EU WC
9 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers, 78 FDA Orange Book, 10 Canada, 4 South Africa, 19 Listed Dossiers

111 FDF Dossiers
78 FDA Orange Book
10 Canada
4 South Africa
19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 17 BASF, 1 CD Formulation, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 15 Kerry, 2 Keval Exports, 3 Lonza Capsugel, 16 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 41 Direct Compression, 34 Disintegrants & Superdisintegrants, 30 Taste Masking, 28 Granulation, 24 Thickeners and Stabilizers, 21 Chewable & Orodispersible Aids, 20 Parenteral, 19 Film Formers & Plasticizers, 14 Lubricants & Glidants, 12 Co-Processed Excipients, 11 Solubilizers, 11 Coating Systems & Additives, 8 Empty Capsules, 7 Controlled & Modified Release, 6 Topical, 5 Emulsifying Agents, 1 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

72 Fillers, Diluents & Binders
41 Direct Compression
34 Disintegrants & Superdisintegrants
30 Taste Masking
28 Granulation
24 Thickeners and Stabilizers
21 Chewable & Orodispersible Aids
20 Parenteral
19 Film Formers & Plasticizers
14 Lubricants & Glidants
12 Co-Processed Excipients
11 Solubilizers
11 Coating Systems & Additives
8 Empty Capsules
7 Controlled & Modified Release
6 Topical
5 Emulsifying Agents
1 API Stability Enhancers
1 Soft Gelatin
1 Rheology Modifiers

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 5 Regulatory FDF Prices

13 US Medicaid Prescriptions
5 Regulatory FDF Prices

MARKET PLACE

12 APIs, 1 FDF Dossiers

12 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents

7 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ API Ref.Price (USD/KG) : 121 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 7EVOKE PHARMA INC

filter Patent Number Reset all filters

7 All

01 18334281

02 111020361

03 111628150

04 111813231

05 112194008

06 112194009

07 112377064

API Patent Reset all filters

7 All

01 7Blank

filter FDF Patent Reset all filters

7 All

01 3Y

02 4Blank

filter Expiration Date Reset all filters

7 All

01 52029-12-22

02 12030-05-16

03 12038-11-17

Product Main Page

01

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 11020361

Drug Substance Claim :

Drug Product Claim :

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 12194009

Drug Substance Claim :

Drug Product Claim :

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 12194008

Drug Substance Claim :

Drug Product Claim :

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-05-16

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 8334281

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-05-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 11628150

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-11-17

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 12377064

Drug Substance Claim :

Drug Product Claim :

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-11-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

EVOKE PHARMA INC

METOCLOPRAMIDE HYDROCHLORIDE

Formnext Forum

Not Confirmed

EVOKE PHARMA INC

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-22

METOCLOPRAMIDE HYDROCHLORIDE

US Patent Number : 11813231

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209388

Patent Use Code : U-2843

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!